Within two years, Highmark Health President and CEO David Holmberg said Tuesday, Allegheny Health Network should have a new academic cancer institute built and operating at its flagship Allegheny General Hospital campus on the North Side.

In that same period, AHN intends to have expanded its network of community-based cancer treatment centers, adding anywhere from four to 10 centers throughout the region with the goal of giving cancer patients care close to where they live.

The two-year time frame is no coincidence.

Three years ago this month, Highmark and competitor UPMC signed state-brokered consent decrees detailing what UPMC services Highmark members could continue to access as the two Pittsburgh health care giants went their separate ways, and UPMC’s Hillman Cancer Center in Shadyside was among the foremost inclusions.

Advertise with us

Those consent decrees expire June 30, 2019.

The upcoming deadline “absolutely” played a role in Highmark Health’s new initiative, Mr. Holmberg said following the public announcement Tuesday at Allegheny General Hospital.

To help position itself for a post-consent decree market, Highmark Health plans to invest more than $200 million in the next two years to expand and enhance its cancer services, creating up to 175 healthcare jobs, while broadening its 3 ½ -year cancer collaboration with the Johns Hopkins Kimmel Cancer Center.

Ground breaking for the new 50,000-square-foot institute, which will be located near the intersection of Sandusky Street and East North Avenue, should begin later this year.

“We are looking forward,” Mr. Holmberg said. “This will make sure that our customers have access to the future of health care, not the past.”

Advertise with us

During the public announcement of the planned institute, Mr. Holmberg said Highmark Health has already invested more than $1 billion to support the seven-hospital Allegheny Health Network as an alternative, and competing, healthcare provider to UPMC’s vast network — adding that AHN has seen 30 percent growth in the last three years.

AHN patients already have had access to 300 clinical trials through Johns Hopkins for treating rare and complex cancers. The enhanced affiliation will double that.

“When you collaborate with Johns Hopkins, you’re collaborating with the best,” said physician David Parda, chairman of the Allegheny Health Network Cancer Institute.

The National Cancer Institute estimated there were about 1.69 million new cases of cancer diagnosed in 2016, and nearly 600,000 cancer deaths.

Meanwhile the number of cancer survivors is expected to grow, from nearly 14.5 million patients in 2014 to close to 19 million by 2024, according to the institute.

Advertise with us

“There’s not a field in medicine that’s changing more rapidly than cancer,” said physician Paul Rothman, dean of the medical faculty and CEO of Johns Hopkins Medicine, who also spoke at Tuesday’s briefing along with fellow physician William Nelson, director of Hopkins’ Kimmel Comprehensive Cancer Center.

Steve Twedt: stwedt@post-gazette.com or 412-263-1963.